American Society of Hematology

Fig. 2.

$Fig. 2. Survival of the patients with AML. / Distinguishing patients that are homozygous (GG and TT) from patients that are heterozygous (GT) for the genetic polymorphism of position 2677 of the MDR1 gene. (A) Time from diagnosis until relapse/refractory disease. (B) Overall survival from relapse/refractory disease. N indicates number of patients investigated; O, observed events.$

Survival of the patients with AML.

Distinguishing patients that are homozygous (GG and TT) from patients that are heterozygous (GT) for the genetic polymorphism of position 2677 of the MDR1 gene. (A) Time from diagnosis until relapse/refractory disease. (B) Overall survival from relapse/refractory disease. N indicates number of patients investigated; O, observed events.

This Feature Is Available To Subscribers Only